Evidence map›Paper›PMID 33810412›Full record

ArticlePharmaceutics2021

Medicine Shortages in Serbia: Pharmacists' Standpoint and Potential Solutions for a Non-EU Country.

Nataša Jovanović Lješković, Aleksandra Jovanović Galović, Svetlana Stojkov, Nikola Jojić, Slobodan Gigov

Abstract read
In one paragraph

Article in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Exploring Drug Shortages in the United Kingdom.Pharmacy (Basel, Switzerland) · 2023
    Article
  6. Article
  7. Community Pharmacy Staff Knowledge, Opinion and Practice toward Drug Shortages in Saudi Arabia.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nataša Jovanović LješkovićFaculty of Pharmacy, University of Business Academy, 21000 Novi Sad, Serbia.
Aleksandra Jovanović GalovićFaculty of Pharmacy, University of Business Academy, 21000 Novi Sad, Serbia.ORCID 0000-0002-9488-9781
Svetlana StojkovFaculty of Pharmacy, University of Business Academy, 21000 Novi Sad, Serbia.
Nikola JojićFaculty of Pharmacy, University of Business Academy, 21000 Novi Sad, Serbia.
Slobodan GigovFaculty of Pharmacy, University of Business Academy, 21000 Novi Sad, Serbia.ORCID 0000-0001-9847-4359

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medicine shortages in Serbia have evidently been present for several decades, but literature data are scarce. The aim of our study was to get an insight on the present situation in Serbia, review the EU actions when managing shortages, and discern a set of potential measures. A short survey was conducted among 500 pharmacists in public pharmacies, in 23 cities in Serbia. The survey questions addressed frequency of drug shortages, professional actions in the event of shortages, main consequences to patients and pharmacies, putative causes, and pivotal measures for the prevention/mitigation of drug shortages under current conditions. Moreover, a Panel of Experts was organized, whose suggestions and opinions were used to analyze the present situation and to form a set of potential solutions and effective measures to mitigate shortages of medicines. In-depth analysis of current Serbian legislation was conducted, with emphasis on specific steps to be made within the actual legal framework. Examples of good practice in the EU, applicable to a country such as Serbia, were examined. Our research showed that although Serbia is, in some aspects, behind EU countries regarding the approaches to overcome medicine shortages, progress can be made within short period of time, by specific well-targeted actions. Both patients and pharmacists would benefit from it.

Indexed as

hospital pharmaciesmedicine shortagesnon-EU countrypublic pharmaciesSerbia

Identifiers

PMID33810412
PMCPMC8066253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.